Your browser doesn't support javascript.
Epigenetic regulation of ACE2, the receptor of the SARS-CoV-2 virus1.
Beacon, Tasnim H; Delcuve, Geneviève P; Davie, James R.
  • Beacon TH; Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
  • Delcuve GP; Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
  • Davie JR; Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, R3E 0J9, Canada.
Genome ; 64(4): 386-399, 2021 Apr.
Article in English | MEDLINE | ID: covidwho-1183386
ABSTRACT
The angiotensin-converting enzyme 2 (ACE2) is the receptor for the three coronaviruses HCoV-NL63, SARS-CoV, and SARS-CoV-2. ACE2 is involved in the regulation of the renin-angiotensin system and blood pressure. ACE2 is also involved in the regulation of several signaling pathways, including integrin signaling. ACE2 expression is regulated transcriptionally and post-transcriptionally. The expression of the gene is regulated by two promoters, with usage varying among tissues. ACE2 expression is greatest in the small intestine, kidney, and heart and detectable in a variety of tissues and cell types. Herein we review the chemical and mechanical signal transduction pathways regulating the expression of the ACE2 gene and the epigenetic/chromatin features of the expressed gene.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Epigenesis, Genetic / Angiotensin-Converting Enzyme 2 Limits: Humans Language: English Journal: Genome Journal subject: Genetics Year: 2021 Document Type: Article Affiliation country: Gen-2020-0124

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Receptors, Virus / Epigenesis, Genetic / Angiotensin-Converting Enzyme 2 Limits: Humans Language: English Journal: Genome Journal subject: Genetics Year: 2021 Document Type: Article Affiliation country: Gen-2020-0124